NeuroLF (Basic); NeuroLF (Pro); NeuroLF (Advanced); NeuroLF Seat— 510(k) K241751

Substantially Equivalent

Positrigo AG

FDA 510(k) clearance K241751 for NeuroLF (Basic); NeuroLF (Pro); NeuroLF (Advanced); NeuroLF Seat, Substantially Equivalent on 2024-07-15. Applicant: Positrigo AG.

Clearance details

Applicant: Positrigo AG
Product code: Code KPS
Advisory panel: Radiology
Date received: 2024-06-18
Decision date: 2024-07-15
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Zurich, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.